Home
Conditions
Scleroderma, Diffuse

Clinical trial condition

Scleroderma, Diffuse

Explore clinical trials studying Scleroderma, Diffuse. Study availability and eligibility vary by location and protocol.

220 public trials 51 recruiting studies

Refine in advanced search Browse all conditions

Scleroderma, Diffuse trial results

Completed

The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy

NCT03141125

Conditions: Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
Locations: Hasan Sadikin Hospital Bandung, West Java, Indonesia

Ciptomangunkusumo Hospital Jakarta, Indonesia

View Trial Details

Completed

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

NCT02349009

Conditions: Connective Tissue Diseases, Scleroderma, Diffuse, Scleroderma, Systemic, +3 more
Locations: Chicago, Illinois, United States

Boston, Massachusetts, United States

New York, United States

View Trial Details

Completed

Psychological Treatments for Scleroderma

NCT00007267

Conditions: Behavior, Behavioral Symptoms, Connective Tissue Diseases, +11 more
Locations: Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study

NCT00341198

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Disease, +18 more
Locations: University of Iowa Iowa City, Iowa, United States

Battelle Centers for Public Health Research and Evaluation Durham, North Carolina, United States

NIEHS, Research Triangle Park Research Triangle Park, North Carolina, United States

View Trial Details

Completed

High Dose Cyclophosphamide for Treatment of Scleroderma

NCT00501995

Conditions: Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
Locations: Not specified

View Trial Details

Completed

Gastroesophageal Reflux Treatment in Scleroderma

NCT01878526

Conditions: Connective Tissue Diseases, Deglutition Disorders, Digestive System Diseases, +11 more
Locations: 123 Department of Medicine, Faculty of Medicine, Khon Kaen University Khon Kaen, Changwat Khon Kaen, Thailand

View Trial Details

Completed

Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers

NCT02801305

Conditions: Connective Tissue Diseases, Digital Ulcer of Scleroderma, Scleroderma, Diffuse, +3 more
Locations: Rheumatology Reseach Center, Shiraz University of Medical Sciences, Shiraz, Iran. Shiraz, Fars, Iran

View Trial Details

Completed

Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)

NCT00883129

Conditions: Connective Tissue Diseases, Dyspnea, Interstitial Lung Disease, +12 more
Locations: David Geffen School of Medicine at UCLA Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

National Jewish Health Denver, Colorado, United States

Georgetown University School of Medicine Washington D.C., District of Columbia, United States

View all 14 locations

View Trial Details

Completed

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

NCT03027674

Conditions: Autoimmune Diseases, Cardiovascular Diseases, Connective Tissue Diseases, +23 more
Locations: Department of Dermatology, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. Santiago, RM, Chile

View Trial Details

Completed

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

NCT02165111

Conditions: Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +12 more
Locations: Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

View Trial Details

Scleroderma, Diffuse

Scleroderma, Diffuse trial results

Related conditions